Best Agrolife (BESTAGRO)

FairStock Score: 38/100 — MIXED

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding of 50.44% keeps management aligned with minority shareholders.
• Debt/Equity at 0.54 and Piotroski F-Score of 6/9 suggest no severe financial distress.
• ROCE of 12.86% and ROE of 10.18% indicate acceptable capital returns in a normal year.
• Trailing profit growth of 47.27% and PEG of 0.50 point to some earnings recovery, though from a weak base.
• Dividend yield of 1.24% offers modest shareholder compensation while waiting.

Concerns

• Latest quarter posted a net loss of ₹13 Cr on sales of ₹203 Cr, while sales growth is -25.97%.
• P/E of 23.65 and P/B of 1.61 leave little margin of safety for a cyclical with uncertain earnings.
• Reported profit growth of 47.27% is contradicted by the latest quarterly loss, suggesting fragile earnings quality.
• Agrochemicals appear commodity-like with no clear durable moat; weather, pricing, and competition can hurt results.

AI Analysis

Let me start with what I love: a simple, understandable business and a strong balance sheet. Best Agrolife makes pesticides and agrochemicals, but that business has no durable economic moat that I can see. The numbers tell a cautionary tale. Sales are down 25.97%, and the latest quarter shows sales of ₹203 Cr and a net loss of ₹13 Cr. That is not the stability Graham demanded. The reported 47.27% profit growth looks impressive until you realize the base is weak and current quarterly earnings have turned negative. At ₹18.13, the stock trades at 23.65 times trailing earnings and 1.61 times book value of ₹11.26. For a cyclical with falling revenue, I need a fat margin of safety; this is not it. The balance sheet is passable—debt/equity of 0.54 and Piotroski score of 6/9—but passable is not excellent. ROCE of 12.86% and ROE of 10.18% are mediocre; they do not signal pricing power or exceptional management. The 1.24% dividend yield is small compensation. Promoter holding of 50.44% is decent, but alignment alone cannot overcome a poor demand environment. Graham would say pay fair price for quality; here I cannot even verify quality. The PEG of 0.50 is a seductive shortcut, but it relies on 47% profit growth continuing; the latest quarterly loss argues otherwise. FairStock rates it 39/100, which is 'mixed' but close to my own cautious view. I will wait for evidence of sustainable demand, positive quarterly profits, and better returns on capital before I consider this a true value candidate. For now, this is a cyclical or turnaround situation, not a stalwart, and the price is not yet compelling.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer